Elsevier

The Lancet Neurology

Volume 9, Issue 9, September 2010, Pages 885-894
The Lancet Neurology

Review
Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond

https://doi.org/10.1016/S1474-4422(10)70183-6Get rights and content

Summary

Cerebellar ataxias with autosomal dominant transmission are rare, but identification of the associated genes has provided insight into the mechanisms that could underlie other forms of genetic or non-genetic ataxias. In many instances, the phenotype is not restricted to cerebellar dysfunction but includes complex multisystemic neurological deficits. The designation of the loci, SCA for spinocerebellar ataxia, indicates the involvement of at least two systems: the spinal cord and the cerebellum. 11 of 18 known genes are caused by repeat expansions in the corresponding proteins, sharing the same mutational mechanism. All other SCAs are caused by either conventional mutations or large rearrangements in genes with different functions, including glutamate signalling (SCA5/SPTBN2) and calcium signalling (SCA15/16/ITPR1), channel function (SCA13/KCNC3, SCA14/PRKCG, SCA27/FGF14), tau regulation (SCA11/TTBK2), and mitochondrial activity (SCA28/AFG3L2) or RNA alteration (SCA31/BEAN-TK2). The diversity of underlying mechanisms that give rise to the dominant cerebellar ataxias need to be taken into account to identify therapeutic targets.

Introduction

The autosomal dominant cerebellar ataxias (ADCAs) are a rare cause of cerebellar ataxia. Most cases of cerebellar ataxia are sporadic, and diagnostic work-up remains a challenge.1, 2 The ADCAs, referred to as spinocerebellar ataxias (SCAs) in genetic nomenclature, are a group of inherited neurological disorders that are clinically and genetically very heterogeneous. They are progressive neurodegenerative diseases that are characterised by cerebellar ataxia, resulting in unsteady gait, clumsiness, and dysarthria. The cerebellar syndrome is often associated with other neurological signs such as pyramidal or extrapyramidal signs, ophthalmoplegia, and cognitive impairment.3 Onset is usually during the third or fourth decade of life, but can occur in childhood or old age. Atrophy of the cerebellum and brainstem are most often the prominent features, but other structures can be affected, leading to a substantial range of phenotypes.4

ADCAs were thought to be exclusively due to expansions of coding CAG repeats, as in the genes that underlie SCA1, SCA2, SCA3, SCA6, SCA7, SCA17, and DRPLA (dentatorubro-pallidoluysian atrophy)—the so-called polyglutamine expansion SCAs. The polyglutamine expansion SCAs share a mutational mechanism with other polyglutamine expansion diseases, such as Huntington disease5 and spinal bulbar muscular atropy,6 and perhaps a pathogenic process, even though most of the proteins involved in polyglutamine expansion diseases have unknown or unrelated functions.7 These disorders manifest above a threshold of CAG repeats that varies depending on the gene. When large and uninterrupted, the CAG repeats are unstable on transmission and result mostly in expansions, particularly during paternal transmissions.8, 9 Correlations between phenotype and genotype in the polyglutamine expansion SCAs have shown that differences in repeat size contribute to variation in disease progression and severity and to some of the clinical differences between patients. The same pathogenetic mechanism applies to SCA subtypes caused by more recently discovered expansions in non-coding regions of genes for SCA10, SCA12, and SCA31—the so-called non-coding-expansion SCAs. The discovery of conventional mutations in some patients with ADCA—the conventional mutation SCAs—in addition to those with dynamic repeats, expands the variety of pathophysiological causes of ADCAs (table 1). Therefore, the different forms of dominantly inherited SCAs, which can no longer be grouped together as polyglutamine expansion disorders, need to be distinguished. This Review will focus on the clinical features of SCAs caused by polyglutamine expansions, non-coding expansions, and rare conventional mutations in SCA genes, and similarities and differences in the phenotypes and underlying pathophysiology between these SCA subtypes will be discussed.

Section snippets

Epidemiology of ADCA subtypes

Between one and three per 100 000 Europeans have ADCA. Polyglutamine expansion SCAs are more frequent than are other forms of SCA, and SCA3 is the most frequent subtype.8 A mean of 44% (SD 25, ranging from 1% to 90% depending on geographical origin) of ADCA cases are still unaccounted for by the genes tested in many series (webappendix). However, in most series, only genes for SCA1, SCA2, SCA3, SCA6, SCA7, and SCA17 were tested. There are founder effects in the genes for SCA2 (40/100 000 cases)

Polyglutamine expansion SCAs

The polyglutamine expansion SCAs caused by translated CAG repeat expansions are the most well studied group of ADCAs. They share the same mutation, a CAG repeat, which manifests above a threshold of CAG repeats that varies according to the gene—usually above 37–40 repeats, but repeats are much smaller in the gene for SCA6 (>19)28 and much larger for SCA3 (>51).29

Non-coding expansion SCAs

In addition to the CAG repeat expansions, untranslated expansions can cause disease through a gain of function mechanism, triggered by the accumulation of transcripts containing expanded CUG or CCUG repeats. A gain in RNA function might have a role, but other mechanisms have also been proposed.58

SCA8 was the first ADCA caused by an untranslated CTG expansion to be described.59 The phenotype is cerebellar ataxia with mild gait spasticity and global cerebellar atrophy.60, 61 Bidirectional

Conventional mutation SCAs

The fastest growing group of known ADCAs is those attributable to conventional, often private, mutations in the associated genes. Screening of these genes is costly and time consuming. Furthermore, interpretion of the identified change and proof of its pathogenicity can be difficult. Only a few families have been identified with some of these mutations, so correlations between phenotype and genotype are difficult to generate.

In 1994, the gene for SCA5 was assigned to the centromeric region of

Clinical features

ADCAs caused by conventional mutations (SCA5, SCA11, SCA13, SCA14, SCA15/16, SCA20, SCA27, and SCA28) are less frequent than are polyglutamine expansion ADCAs.20 The overall phenotype of patients with conventional mutations differs from that of patients with polyglutamine expansions (table 3). Polyglutamine expansion SCAs can lead to substantial neurological dysfunction and are fatal, whereas lifespan is healthy in patients with conventional mutation SCAs. Onset is most often in childhood, but

Conclusions

When should a patient with progressive cerebellar ataxia be tested for SCAs? The patient should have a family history of the disease before genes associated with ADCAs are tested. Repeat expansions in SCA1, SCA2, and SCA3 cause about 40–80% of autosomal dominant cerebellar ataxias, depending on the population (webappendix). These expansions can be searched for in sporadic cases, especially if the family history is unknown (eg, if the patient is adopted), the parents died before reaching the age

Search strategy and selection criteria

References for the Review were identified through searches of PubMed from 1996, to June, 2010, by use of the following search terms: “spinocerebellar ataxia” OR “autosomal dominant cerebellar ataxia” OR “SCA”. Only papers published in English were considered. Studies were selected on the basis of relevance as judged by the author.

References (112)

  • N Sato et al.

    Spinocerebellar ataxia type 31 is associated with “inserted” penta-nucleotide repeats containing (TGGAA)n

    Am J Hum Genet

    (2009)
  • PF Worth et al.

    Autosomal dominant cerebellar ataxia type III: linkage in a large British family to a 7.6-cM region on chromosome 15q14-21.3

    Am J Hum Genet

    (1999)
  • A Herman-Bert et al.

    Mapping of spinocerebellar ataxia 13 to chromosome 19q13.3-q13.4 in a family with autosomal dominant cerebellar ataxia and mental retardation

    Am J Hum Genet

    (2000)
  • DH Chen et al.

    Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia

    Am J Hum Genet

    (2003)
  • JC van Swieten et al.

    A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebellar ataxia corrected

    Am J Hum Genet

    (2003)
  • BL Fogel et al.

    An approach to the patient with late-onset cerebellar ataxia

    Nat Clin Pract

    (2006)
  • M Yamada et al.

    CAG repeat disorder models and human neuropathology: similarities and differences

    Acta Neuropathol

    (2008)
  • A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes

    Cell

    (1993)
  • AR La Spada et al.

    Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy

    Nature

    (1991)
  • AJ Williams et al.

    Polyglutamine neurodegeneration: protein misfolding revisited

    Trends Neurosci

    (2008)
  • G Stevanin et al.

    Clinical and molecular advances in autosomal dominant cerebellar ataxias: from genotype to phenotype and physiopathology

    Eur J Hum Genet

    (2000)
  • J Sequeiros et al.

    Epidemiology and clinical aspects of Machado-Joseph disease

    Adv Neurol

    (1993)
  • J Vale et al.

    Autosomal dominant cerebellar ataxia: frequency analysis and clinical characterization of 45 families from Portugal

    Eur J Neurol

    (2010)
  • HA Teive et al.

    Spinocerebellar ataxia type 6 in Brazil

    Arq Neuropsiquiatr

    (2008)
  • B Tang et al.

    Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds

    Arch Neurol

    (2000)
  • R Basri et al.

    Spectrum and prevalence of autosomal dominant spinocerebellar ataxia in Hokkaido, the northern island of Japan: a study of 113 Japanese families

    J Hum Genet

    (2007)
  • H Maruyama et al.

    Difference in disease-free survival curve and regional distribution according to subtype of spinocerebellar ataxia: a study of 1,286 Japanese patients

    Am J Med Genet

    (2002)
  • A Shibata-Hamaguchi et al.

    Prevalence of spinocerebellar degenerations in the Hokuriku district in Japan

    Neuroepidemiology

    (2009)
  • BP van de Warrenburg et al.

    Spinocerebellar ataxias in the Netherlands: prevalence and age at onset variance analysis

    Neurology

    (2002)
  • L Schols et al.

    Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined subtypes?

    Ann Neurol

    (1997)
  • A Durr et al.

    Conventional mutations are associated with a different phenotype than polyglutamine expansions in spinocerebellar ataxias

    Eur J Hum Genet

    (2009)
  • S Kraft et al.

    Adult onset spinocerebellar ataxia in a Canadian movement disorders clinic

    Can J Neurol Sci

    (2005)
  • ML Moseley et al.

    Incidence of dominant spinocerebellar and Friedreich triplet repeats among 361 ataxia families

    Neurology

    (1998)
  • M Faruq et al.

    SCA-LSVD: a repeat-oriented locus-specific variation database for genotype to phenotype correlations in spinocerebellar ataxias

    Hum Mutat

    (2009)
  • AK Erichsen et al.

    Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based study

    Brain

    (2009)
  • A Brusco et al.

    Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families

    Arch Neurol

    (2004)
  • Marelli C VDLJ, Johnson JO, Tison F, et al. SCA15 due to ITPR1 deletions in a large cohort of Caucasian families with...
  • HA Teive et al.

    Clinical phenotype of Brazilian families with spinocerebellar ataxia 10

    Neurology

    (2004)
  • C Jodice et al.

    Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p

    Hum Mol Genet

    (1997)
  • W Gu et al.

    The shortest expanded allele of the MJD1 gene in a Chinese MJD kindred with autonomic dysfunction

    Eur Neurol

    (2004)
  • G David et al.

    Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7)

    Hum Mol Genet

    (1998)
  • SM Pulst et al.

    Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset

    Brain

    (2005)
  • BP van de Warrenburg et al.

    Age at onset variance analysis in spinocerebellar ataxias: a study in a Dutch-French cohort

    Ann Neurol

    (2005)
  • A Durr et al.

    Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features

    Ann Neurol

    (1996)
  • SS Chong et al.

    Gametic and somatic tissue-specific heterogeneity of the expanded SCA1 CAG repeat in spinocerebellar ataxia type 1

    Nat Genet

    (1995)
  • G Cancel et al.

    Somatic mosaicism of the CAG repeat expansion in spinocerebellar ataxia type 3/Machado-Joseph disease

    Hum Mutat

    (1998)
  • M Swami et al.

    Somatic expansion of the Huntington's disease CAG repeat in the brain is associated with an earlier age of disease onset

    Hum Mol Genet

    (2009)
  • C Globas et al.

    Early symptoms in spinocerebellar ataxia type 1, 2, 3, and 6

    Mov Disord

    (2008)
  • A Durr et al.

    Clinical and genetic aspects of spinocerebellar degeneration

    Curr Opin Neurol

    (2000)
  • T Ikeuchi et al.

    Dentatorubral-pallidoluysian atrophy: clinical features are closely related to unstable expansions of trinucleotide (CAG) repeat

    Ann Neurol

    (1995)
  • Cited by (524)

    View all citing articles on Scopus
    View full text